Physician profile
David Glen Heiser
NPI 1750380861
$4,651.48
in general payments reported to CMS, 2019-2025
38 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $837 · 2021: $1,353 · 2022: $1,002 · 2023: $222 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $881.96 | 2019-2022 | |
| Allergan, INC. | $605.91 | 2019-2022 | |
| Abbvie INC. | $409.99 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $279.16 | 2019-2023 | Xiaflex |
| Neotract INC. | $175.31 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.75 | 2019-2021 | |
| Myovant Sciences INC. | $170.80 | 2021-2022 | |
| Urovant Sciences INC | $169.57 | 2021-2022 | |
| Axonics, INC. | $162.39 | 2021-2022 | |
| Blue Earth Diagnostics | $159.98 | 2019-2022 | |
| Janssen Biotech, INC. | $146.09 | 2019-2022 | |
| Teleflex LLC | $140.02 | 2021-2025 | Barrigel |
| Urogen Pharma, INC. | $131.76 | 2020-2022 | |
| Olympus America INC. | $112.59 | 2025 | Itind System |
| Boston Scientific Corporation | $112.07 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $98.93 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $90.32 | 2025 | Gemtesa |
| Antares Pharma, INC. | $74.92 | 2019-2022 | |
| Clarus Therapeutics INC. | $47.20 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $44.60 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $41.86 | 2021-2022 | |
| Medtronic, INC. | $37.24 | 2022 | |
| Amgen INC. | $36.71 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.58 | 2021-2022 | |
| Pfizer INC. | $36.17 | 2019 | |
| Travere Therapeutics, INC. | $32.00 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $31.85 | 2019 | |
| Accord Healthcare, INC. | $30.69 | 2022 | |
| Dentsply Ih INC. | $29.26 | 2019-2020 | |
| Medtronic USA, INC. | $27.21 | 2020 | |
| Coloplast Corp | $25.25 | 2019 | |
| Progenics Pharmaceuticals, INC. | $16.73 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.72 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.15 | 2020 | |
| Palette Life Sciences, INC. | $13.87 | 2022 | |
| Ambu INC. | $13.13 | 2020 | |
| Richard Wolf Medical Instruments Corp. | $12.64 | 2019 | |
| Genzyme Corporation | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.